MedTrace Logo

Special Drug Use Investigation for ADOAIR DISKUS COPD (Salmeterol and Fluticasone)

NCT01332409 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2013-06-10

No results posted yet for this study

Summary

To investigate possible problems or questions in safety and effectiveness of salmeterol and fluticasone in patients with chronic obstructive pulmonary disease (bronchitis chronic / emphysema). In this special drug use investigation, onset of pneumonia shall be handled as the priority investigation item.

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Salmeterol and Fluticasone

Administered according to the prescribing information in the locally approved label by the authorities.

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2012-04-30
Completion
2013-01-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01332409 on ClinicalTrials.gov